A comparison between the effects of low (1 ?g) and standard dose (250 ?g) ACTH stimulation tests on adrenal cortex functions with leprosy patients

dc.contributor.authorÇolak, R
dc.contributor.authorOzkan, Y
dc.contributor.authorÖnen, SE
dc.contributor.authorSaral, Y
dc.contributor.authorHalifeoglu, I
dc.date.accessioned2026-08-12T17:02:28Z
dc.date.issued2005
dc.departmentFırat Üniversitesi
dc.description.abstractLeprosy is a chronic granulomatous disease that either remains localized or widespread depending on the immunological status of the affected patient. It can lead to clinical or subclinical adrenal failure by influencing adrenal steroidogenesis. In the present study, 26 patients (21 males and 5 females) who were diagnosed with lepromatous leprosy and 15 healthy individuals who were compatible with the patients in terms of age and sex were subjected to an adrenocorticotrophic hormone (ACTH) stimulation test. The leprosy and control groups were subjected to 1 mu g low dose (LDT) and 250 mu g intravenous standard dose (SDT) ACTH stimulation tests after 12-hour nocturnal fasting with an interval of three days. Cortisol responses in 0, 30, and 60 minutes were examined. There was no difference between leprosy and control groups in terms of mean baseline cortisol values. Mean value of the peak cortisol response to both LDT and SDT was found to be significantly lower in the leprosy group than in the control group (p < 0.001 and p < 0.01, respectively). Peak cortisol response to LDT in the leprosy group was found below 20 mu g/dL in 9 patients (34.6%). As for the peak cortisol response to SDI; it was lower than 20 mu g/dL in 5 patients (19.23%). It was found that LDT response was abnormally low in 4 patients (15.38%) who responded normally to SDT. It was observed that there could be a decrease in adrenocortical reserve capacity although baseline adrenocortical functions were normal in patients with leprosy. It was seen that LDT was more sensitive than SDT in identifying this decrease.
dc.identifier.doi10.1080/07435800500449478
dc.identifier.endpage333
dc.identifier.issn0743-5800
dc.identifier.issn1532-4206
dc.identifier.issue4
dc.identifier.pmid16433251
dc.identifier.scopus2-s2.0-32144464189
dc.identifier.scopusqualityQ3
dc.identifier.startpage325
dc.identifier.urihttps://doi.org/10.1080/07435800500449478
dc.identifier.urihttps://hdl.handle.net/11508/48158
dc.identifier.volume31
dc.identifier.wosWOS:000234749000007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofEndocrine Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectleprosy
dc.subjectadrenal failure
dc.subjectACTH stimulation test
dc.titleA comparison between the effects of low (1 ?g) and standard dose (250 ?g) ACTH stimulation tests on adrenal cortex functions with leprosy patients
dc.typeArticle

Dosyalar